Page 1 | Search Results | Hematology, ASH Education Program

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Myeloma: next generation immunotherapy

Adam D. Cohen

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 266–272.

https://doi.org/10.1182/hematology.2019000068

Published: 2019

Journal Articles

CAR T-cell therapy: is it prime time in myeloma?

Surbhi Sidana, Nina Shah

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 260–265.

https://doi.org/10.1182/hematology.2019000370

Published: 2019

Journal Articles

Advances and practical use of monoclonal antibodies in multiple myeloma therapy

Hans C. Lee, Donna M. Weber

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 512–520.

https://doi.org/10.1182/asheducation-2016.1.512

Published: 2016

Journal Articles

Implications of new prognostic markers in chronic lymphocytic leukemia

Nicholas Chiorazzi

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 76–87.

https://doi.org/10.1182/asheducation.V2012.1.76.3806845

Published: 2012

Journal Articles

New Prognostic Markers in CLL

Emili Montserrat

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 279–284.

https://doi.org/10.1182/asheducation-2006.1.279

Published: 2006

NARROW

Myeloma: next generation immunotherapy

CAR T-cell therapy: is it prime time in myeloma?

Advances and practical use of monoclonal antibodies in multiple myeloma therapy

Implications of new prognostic markers in chronic lymphocytic leukemia

New Prognostic Markers in CLL

ASH Publications

American Society of Hematology

Myeloma: next generation immunotherapy

CAR T-cell therapy: is it prime time in myeloma?

Advances and practical use of monoclonal antibodies in multiple myeloma therapy

Implications of new prognostic markers in chronic lymphocytic leukemia

New Prognostic Markers in CLL

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only